| Detailed information |
|---|
| CancerLivER ID | 2200 |
| Biomarker | AFP, (with cut off 0.9 of AFP in serum ) |
| Biomarker Name/Symbol (given in Publication) | sAFP (with cut off 0.9 of sAFP ) |
| Biomolecule | Protein |
| Subject | Human |
| Degree of Validity | Biomarker for HCC diagnosis; but not validated on independent dataset |
| Experimental Condition | HCC v/s Non-HCC |
| Cancer type | Hepatocellular carcinoma |
| Regulation | NA |
| Level of significance | NA |
| Source | Serum and Urine |
| PMID | 29152526 |
| Type of Biomarker | Diagnostic |
| Pathway | NA |
| Cohort | 203 non-HCC patients either cirrhosis (106) or hepatitis (97) and 84 HCC patients |
| Sensitivity | 63.10% |
| Specificity | 90% |
| Accuracy | NA |
| AUC | 0.766 |
| Disease | Human HCC |
| Year of Publication | 2017 |
| Clinical trial | YES |
| NCT No# (Clinical trial) | NCT00005629,NCT03132792,NCT00513461,NCT00093548,NCT01350167,NCT02435433,NCT02072356,NCT02582918,NCT02232490,NCT01128803,NCT02312817,NCT01849588,NCT03156582,NCT03533582,NCT03767764,NCT01078311,NCT03493763,NCT00980460,NCT00629421,NCT01392131,NCT0174764 |